Read Books Online and Download eBooks, EPub, PDF, Mobi, Kindle, Text Full Free.
How To Commercialise Research In Biotechnology
Download How To Commercialise Research In Biotechnology full books in PDF, epub, and Kindle. Read online How To Commercialise Research In Biotechnology ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Book Synopsis How to Commercialise Research in Biotechnology? by : Oliver Uecke
Download or read book How to Commercialise Research in Biotechnology? written by Oliver Uecke and published by Springer Science & Business Media. This book was released on 2012-04-29 with total page 336 pages. Available in PDF, EPUB and Kindle. Book excerpt: Biotechnology is considered as a key technology of the 21st century with the potential to offer technological solutions for global health and resource-based problems. Oliver Uecke analyses how early stages of the innovation process in biotechnology can be effectively managed, with the aim to transfer an innovation from academia to industry. A mixed method approach is applied with a multiple case study approach to identify characteristics for effective management and with the method of discrete choice experiments/best-worst scaling to estimate the importance of these characteristics. This study adds to existing research by identifying a group of five important characteristics that should be considered in the early stages of the innovation process, compared to a group of four characteristics that are less important. The results have implications for policy, directors and the management of research institutes and universities, entrepreneurs, TTO manager and other stakeholders involved in technology transfer.
Download or read book Commercial Biotechnology written by and published by . This book was released on 1984 with total page 28 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Biotechnology Business - Concept to Delivery by : Arpita Saxena
Download or read book Biotechnology Business - Concept to Delivery written by Arpita Saxena and published by Springer Nature. This book was released on 2020-02-15 with total page 197 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book is an effort to foster the entrepreneurial spirit in young minds. It reviews a wide range of product ideas, opportunities and challenges associated with start-ups. In addition, it discusses popular molecular targets for biotechnology research / the biotech industry such as attenuated microbes, gene sequences, biomarkers, and the latest advance in the sector, CRISPR. These molecular targets can be modified for the production of sufficient quantities of food and fuel. Very often, researchers limit their focus to the proof of concept, and fail to successfully convert it into a finished product. To help young entrepreneurs avoid this pitfall, the book addresses various aspects like intellectual property regulations, commerce and management. The book’s contributing authors hail from various specialized sectors, and from around the globe. Taken together, the respective chapters are intended to overcome the borders between disciplines that otherwise rarely interact.
Book Synopsis The Business of Bioscience by : Craig D. Shimasaki
Download or read book The Business of Bioscience written by Craig D. Shimasaki and published by Springer Science & Business Media. This book was released on 2009-09-18 with total page 282 pages. Available in PDF, EPUB and Kindle. Book excerpt: My journey into this fascinating field of biotechnology started about 26 years ago at a small biotechnology company in South San Francisco called Genentech. I was very fortunate to work for the company that begat the biotech industry during its formative years. This experience established a solid foundation from which I could grow in both the science and business of biotechnology. After my fourth year of working on Oyster Point Boulevard, a close friend and colleague left Genentech to join a start-up biotechnology company. Later, he approached me to leave and join him in of all places – Oklahoma. He persisted for at least a year before I seriously considered his proposal. After listening to their plans, the opportunity suddenly became more and more intriguing. Finally, I took the plunge and joined this ent- preneurial team in cofounding and growing a start-up biotechnology company. Making that fateful decision to leave the security of a larger company was extremely difficult, but it turned out to be the beginning of an entrepreneurial career that forever changed how I viewed the biotechnology industry. Since that time, I have been fortunate to have cofounded two other biotechnology com- nies and even participated in taking one of them public. During my career in these start-ups, I held a variety of positions, from directing the science, operations, regulatory, and marketing components, to subsequently becoming CEO.
Book Synopsis Effective Technology Transfer in Biotechnology by : Oliver Uecke
Download or read book Effective Technology Transfer in Biotechnology written by Oliver Uecke and published by World Scientific. This book was released on 2015-01-06 with total page 292 pages. Available in PDF, EPUB and Kindle. Book excerpt: Biotechnology is referred to as one of the key enabling technologies of the 21st century. It has the potential to offer solutions for a number of health and resource-based problems the world is facing, such as unmet medical needs and fossil fuel dependency. Considerable effort and investment has been expended in recent years to try and improve the outcomes of technology transfer in order to fulfill this potential. This book presents seventeen best-practice case studies on the topic of effective technology transfer in biotechnology. The selected case studies focus on technology transfer offices, funding models, incubators, education and clusters. Each presents an overview of an initiative that was deployed in Europe with the aim of supporting and stimulating the transfer of biotechnology discoveries and technologies from research laboratories to society. Readers are provided with a critical assessment of each initiative and policy makers, entrepreneurs, cluster managers and research institute managers will find inspiring lessons they can draw on when developing and implementing similar initiatives elsewhere. These cases are the product of research undertaken as part of the ETTBio (Effective Technology Transfer in Biotechnology) project, co-financed by the European Union (ERDF — European Regional Development Fund) and made possible by the INTERREG IVC Programme. ETTBio commenced in January 2012 and concluded in December 2014. Contents:Technology Transfer Office (TTO):Case Study 1: A Look Inside Imperial College's TTOCase Study 2: Technology Transfer at VIBCase Study 3: The Creation of a New Technology Transfer OfficeCase Study 4: A Model for IP Transfer and Shareholding for University Spin-Offs: The "Dresden Model"Funding:Case Study 5: Environmental Success Factors of Imperial College's TTOCase Study 6: The Industrial Research FundCase Study 7: Regional Innovation Vouchers as an Effective Tool for Supporting Technology TransferCase Study 8: Public Funds for Patenting, Valorization and Science-Industry CollaborationIncubators:Case Study 9: The Imperial BioincubatorCase Study 10: Idea Lab — A Platform for Students to Develop New IdeasEducation:Case Study 11: Entrepreneurship and Technology Transfer Education at the Vrije Universiteit BrusselCase Study 12: BioEmprenedor XXI: Guidance Program for Starting Up and Growing Companies in the Life Sciences ArenaCase Study 13: Education for ScientistsClusters:Case Study 14: The Biocat Model: Managing the Bioregion of CataloniaCase Study 15: The Effects of a Cluster on a Spin-Off — The Foundation of AblynxCase Study 16: Brokerage Event: Matching International R&D projectsCase Study 17: The DRESDEN-concept: A Focus on Shared Services and Facilities Readership: Policy makers, entrepreneurs, cluster managers and research institute managers in biotechnology. Key Features:Focuses on effective technology transfer in the European contextTechnology specific focus on biotechnologyIdentifies and provides a detailed examination of best practice case studies in technology transfer across Europe. These include both highly experienced regions such as London and Flanders as well as "newcomers" such as Poland and EstoniaKeywords:Technology Transfer;Biotechnology;Effectiveness;Efficiency;Commercialization;Research;Funding;Cluster;Education;Technology Transfer Offices;Incubation
Book Synopsis Technology Transfer by : Neil F. Sullivan
Download or read book Technology Transfer written by Neil F. Sullivan and published by Cambridge University Press. This book was released on 1995-11-16 with total page 240 pages. Available in PDF, EPUB and Kindle. Book excerpt: The purpose of this book is to help research scientists exploit their ideas commercially.
Book Synopsis From Breakthrough to Blockbuster by : Donald L. Drakeman
Download or read book From Breakthrough to Blockbuster written by Donald L. Drakeman and published by Oxford University Press. This book was released on 2022 with total page 241 pages. Available in PDF, EPUB and Kindle. Book excerpt: "Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. How could a large collection of small companies, most with fewer than 50 employees, compete in one of the world's most breathtakingly expensive and highly regulated industries? This book shows how biotech companies have met the challenge by creating nearly 40% more of the most important treatments for unmet medical needs. Moreover, they have done so with much lower overall costs. The book focuses on both the companies themselves and the broader biotech ecosystem that supports them. Its portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies shows how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions. Looking to the future, it concludes that biomedical research will continue to be most effective in the hands of a large group of small companies as long as national healthcare policies allow the rest of the ecosystem to continue to thrive"--
Book Synopsis Business Modeling for Life Science and Biotech Companies by : Alberto Onetti
Download or read book Business Modeling for Life Science and Biotech Companies written by Alberto Onetti and published by Routledge. This book was released on 2014-03-21 with total page 212 pages. Available in PDF, EPUB and Kindle. Book excerpt: Most books on the biotechnology industry focus on scientific and technological challenges, ignoring the entrepreneurial and managerial complexities faced bio-entrepreneurs. The Business Models for Life Science Firms aims to fill this gap by offering managers in this rapid growth industry the tools needed to design and implement an effective business model customized for the unique needs of research intensive organizations. Onetti and Zucchella begin by unpacking the often-used ‘business model’ term, examining key elements of business model conceptualization and offering a three tier approach with a clear separation between the business model and strategy: focus, exploring the different activities carried out by the organization; locus, evaluating where organizational activities are centered; and modus, testing the execution of the organization’s activities. The business model thus defines the unique way in which a company delivers on its promise to its customers. The theory and applications adopt a global approach, offering business cases from a variety of biotech companies around the world.
Book Synopsis Biotechnology Entrepreneurship by : Craig Shimasaki
Download or read book Biotechnology Entrepreneurship written by Craig Shimasaki and published by Academic Press. This book was released on 2014-04-08 with total page 488 pages. Available in PDF, EPUB and Kindle. Book excerpt: As an authoritative guide to biotechnology enterprise and entrepreneurship, Biotechnology Entrepreneurship and Management supports the international community in training the biotechnology leaders of tomorrow. Outlining fundamental concepts vital to graduate students and practitioners entering the biotech industry in management or in any entrepreneurial capacity, Biotechnology Entrepreneurship and Management provides tested strategies and hard-won lessons from a leading board of educators and practitioners. It provides a ‘how-to’ for individuals training at any level for the biotech industry, from macro to micro. Coverage ranges from the initial challenge of translating a technology idea into a working business case, through securing angel investment, and in managing all aspects of the result: business valuation, business development, partnering, biological manufacturing, FDA approvals and regulatory requirements. An engaging and user-friendly style is complemented by diverse diagrams, graphics and business flow charts with decision trees to support effective management and decision making. Provides tested strategies and lessons in an engaging and user-friendly style supplemented by tailored pedagogy, training tips and overview sidebars Case studies are interspersed throughout each chapter to support key concepts and best practices. Enhanced by use of numerous detailed graphics, tables and flow charts
Book Synopsis Business of Biotechnology by : R. Ono
Download or read book Business of Biotechnology written by R. Ono and published by Elsevier. This book was released on 2013-10-22 with total page 392 pages. Available in PDF, EPUB and Kindle. Book excerpt: The Business of Biotechnology: From the Bench to the Street thoroughly examines the existing and future business challenges for biotechnology, providing a unique insight into the intricate web of critical factors with which biotechnology entrepreneurs must come to terms if they wish to be successful. The book begins with discussions of the evolution of biotechnology; entrepreneurship in the biotechnology industry; university-industry technology transfer process; and the life cycle of a biotechnology company. It considers the prospects for biotechnology, from the perspective of a venture capitalist and human resource practitioner. There are separate chapters that deal with the cloning and expression of recombinant gene products; developing strategies to reduce the cost-to-produce (CTP) therapeutic proteins; intellectual property protection; and the regulation of commercial biotechnology. The final chapters cover the marketing of biotechnology companies and products; the performance of biotechnology stocks; mergers and acquisitions in the biotechnology industry, and prospects for the Japanese and European biotechnology industry.
Book Synopsis Science Business by : Gary P. Pisano
Download or read book Science Business written by Gary P. Pisano and published by Harvard Business Press. This book was released on 2006 with total page 278 pages. Available in PDF, EPUB and Kindle. Book excerpt: Why has the biotechnology industry failed to perform up to expectations? This book attempts to answer this question by providing a critique of the industry. It reveals the causes of biotech's problems and offers an analysis on how the industry works. It also provides prescriptions for companies, seeking ways to improve the industry's performance.
Book Synopsis Biotech Industry by : Bryan Bergeron
Download or read book Biotech Industry written by Bryan Bergeron and published by John Wiley & Sons. This book was released on 2004-04-12 with total page 384 pages. Available in PDF, EPUB and Kindle. Book excerpt: "The biotech industry is a complex, rapidly evolving, and critical industry. The industry holds great commercial and societal promise, but it is also filled with hype, confusion, and risks. Bergeron and Chan do a remarkable job of providing a sweeping insightful, and probing assessment of the current state and likely evolution of this global industry. This book is essential reading for the executive who desires a thorough understanding of this business and its potential."--John P. Glasser, Vice President and Chief Information Offers, Partners Healthcare System, Inc. "Bergeron and Chan have done a marvelous job integrating many different perspectives to give the reader a coherent road map of the biotech industry for the next decade. This powerful book is anchored by numerous relevant examples that create a framework which any life sciences professional needs to understand. Of particular note is the compelling assessment of the IT industry and its impact on the life sciences as these industries converge."--Michael A. Greeley, Managing General Partner, IDG Ventures. An in-depth examination of the growth and financing of the biotechnology industry worldwide Biotech Industry: A Global, Economic, and Financing Overview provides a thorough look at the current state of the biotechnology industry, including where major research is being conducted, where it's being applied, and where money and intellectual capital are flowing. Written by a renowned business columnist and an entrepreneurial scientist in the biotech area, this unique book gives Eos and other senior-level managers an understanding of Asia's pivotal role in the worldwide success of biotechnology commercialization, as well as insight into the biotech market over the next decade.
Book Synopsis Business Development for the Biotechnology and Pharmaceutical Industry by : Martin Austin
Download or read book Business Development for the Biotechnology and Pharmaceutical Industry written by Martin Austin and published by CRC Press. This book was released on 2016-04-08 with total page 202 pages. Available in PDF, EPUB and Kindle. Book excerpt: Business Development in the biotechnology and pharmaceutical industries accounts for over $5 billion in licensing deal value per year and much more than that in the value of mergers and acquisitions. Transactions range from licences to patented academic research, to product developments as licences, joint ventures and acquisition of intellectual property rights, and on to collaborations in development and marketing, locally or across the globe. Asset sales, mergers and corporate takeovers are also a part of the business development remit. The scope of the job can be immense, spanning the life-cycle of products from the earliest levels of research to the disposal of residual marketing rights, involving legal regulatory manufacturing, clinical development, sales and marketing and financial aspects. The knowledge and skills required of practitioners must be similarly broad, yet the availability of information for developing a career in business development is sparse. Martin Austin's highly practical guide spans the complete process and is based on his 30 years of experience in the industry and the well-established training programme that he has developed and delivers to pharmaceutical executives from across the world.
Book Synopsis Handbook of Bioentrepreneurship by : Holger Patzelt
Download or read book Handbook of Bioentrepreneurship written by Holger Patzelt and published by Springer Science & Business Media. This book was released on 2008-10-11 with total page 296 pages. Available in PDF, EPUB and Kindle. Book excerpt: Providing an important and timely overview of research on the exciting area of entrepreneurship in biotechnology, The Handbook of Bioentrepreneurship examines one of the most promising industries of the 21st century. While genetically engineered food and biopharmaceuticals have made biotechnology part of our everyday life, starting a bioventure is among the most complex and risky entrepreneurial tasks given long development cycles, high technological and market uncertainty, and high capital intensity. Providing unparalleled in-depth and detailed analysis, this Handbook sheds light on business models and strategies, financing, cooperation networks between firms and universities, among other issues. With new developments in biotechnology increasingly in the news, this is an important source for readers interested in public policy, entrepreneurship, and business in the 21st century.
Download or read book Commercial Biotechnology written by and published by . This book was released on 1989 with total page 674 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Author :United States. Congress. House. Committee on Science, Space, and Technology. Subcommittee on Technology and Competitiveness Publisher : ISBN 13 : Total Pages :186 pages Book Rating :4.0/5 (18 download)
Book Synopsis Commercialization of Biotechnology by : United States. Congress. House. Committee on Science, Space, and Technology. Subcommittee on Technology and Competitiveness
Download or read book Commercialization of Biotechnology written by United States. Congress. House. Committee on Science, Space, and Technology. Subcommittee on Technology and Competitiveness and published by . This book was released on 1992 with total page 186 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Managing Biotechnology by : Francoise Simon
Download or read book Managing Biotechnology written by Francoise Simon and published by John Wiley & Sons. This book was released on 2017-10-16 with total page 322 pages. Available in PDF, EPUB and Kindle. Book excerpt: A comprehensive overview of the new business context for biopharma companies, featuring numerous case studies and state-of-the-art marketing models Biotechnology has developed into a key innovation driver especially in the field of human healthcare. But as the biopharma industry continues to grow and expand its reach, development costs are colliding with aging demographics and cost-containment policies of private and public payers. Concurrently, the development and increased affordability of sophisticated digital technologies has fundamentally altered many industries including healthcare. The arrival of new information technology (infotech) companies on the healthcare scene presents both opportunities and challenges for the biopharma business model. To capitalize on new digital technologies from R&D through commercialization requires industry leaders to adopt new business models, develop new digital and data capabilities, and partner with innovators and payers worldwide. Written by two experts, both of whom have had decades of experience in the field, this book provides a comprehensive overview of the new business context and marketing models for biotech companies. Informed by extensive input by senior biotech executives and leading consultancies serving the industry, it analyzes the strategies and key success factors for the financing, development, and commercialization of novel therapeutic products, including strategies for engagement with patients, physicians and healthcare payers. Throughout case studies provide researchers, corporate marketers, senior managers, consultants, financial analysts, and other professionals involved in the biotech sector with insights, ideas, and models. JACQUALYN FOUSE, PhD, RETIRED PRESIDENT AND CHIEF OPERATING OFFICER, CELGENE “Biotech companies have long been innovators, using the latest technologies to enable cutting edge science to help patients with serious diseases. This book is essential to help biotech firms understand how they can–and must–apply the newest technologies including disruptive ones, alongside science, to innovate and bring new value to the healthcare system.” BRUCE DARROW, MD, PhD, CHIEF MEDICAL INFORMATION OFFICER, MOUNT SINAI HEALTH SYSTEM “Simon and Giovannetti have written an essential user’s manual explaining the complicated interplay of the patients who deserve cutting-edge medical care, the biotechnology companies (big and small) creating the breakthroughs, and the healthcare organizations and clinicians who bridge those worlds.” EMMANUEL BLIN, FORMER CHIEF STRATEGY OFFICER AND SENIOR VICE PRESIDENT, BRISTOL-MYERS SQUIBB “If you want to know where biopharma is going, read this book! Our industry is facing unprecedented opportunities driven by major scientific breakthroughs, while transforming itself to address accelerated landscape changes driven by digital revolutions and the emergence of value-based healthcare worldwide. In this ever-changing context, we all need to focus everything we do on the patients. They are why we exist as an industry, and this is ultimately what this insightful essay is really about.” JOHN MARAGANORE, PRESIDENT AND CHIEF EXECUTIVE OFFICER, ALNYLAM PHARMACEUTICALS “Since the mapping of the human genome was completed nearly 15 years ago, the biotechnology industry has led the rapid translation of raw science to today’s innovative medicines. However, the work does not stop in the lab. Delivering these novel medicines to patients is a complex and multifaceted process, which is elegantly described in this new book.”
